No price history available.
Key financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ¥m | 77,722 | 79,231 | 88,750 | 91,484 | 95,582 | 96,300 | N/A | N/A |
| Operating profit | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | ¥m | -1,618 | 21,582 | 6,414 | 8,755 | 9,389 | 7,036 | N/A | N/A |
| EPS reported | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Riken Vitamin Co., Ltd., based in Tokyo, Japan, operates across several key sectors: food ingredients, food applications, healthcare, and chemicals. The company provides a diverse portfolio of food additives, including emulsifiers used in a wide array of products such as baked goods (bread, cake), desserts (whipped topping, ice cream), dairy items (coffee cream, margarine), and other food preparations like tofu, jam, marmalade, cocoa, chocolate, noodles, and mashed potatoes. A specific offering is distilled diglycerine ester, a compound resulting from the interaction of diglycerine with fatty acids. To prolong shelf life, Riken Vitamin supplies natural tocopherol, an antioxidant that prevents oxidation and maintains food freshness. Their product line further encompasses natural food colors and various flavorings suitable for seasoning seafood, poultry, and beef. The company also deals in wakame seaweed, frequently utilized in soups, salads, and instant noodle preparations, alongside integrated stabilizing and emulsifying solutions for frozen treats and dairy products. Additionally, they develop specialized bakery emulsifiers, bread improvers, and cake-enhancing agents. In the chemical realm, Riken Vitamin offers various improving agents, including glycerol, polyglycerol, sorbitan, propylene glycol, and other specialty esters, in addition to vitamins. Established in 1917, the company was initially known as Riken Vitamin Oil Co., Ltd. before rebranding as Riken Vitamin Co., Ltd. in 1980.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Riken Vitamin Co., Ltd. (4526.T)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Riken Vitamin Co., Ltd., based in Tokyo, Japan, operates across several key sectors: food ingredients, food applications, healthcare, and chemicals. The company provides a diverse portfolio of food additives, including emulsifiers used in a wide array of products such as baked goods (bread, cake), desserts (whipped topping, ice cream), dairy items (coffee cream, margarine), and other food preparations like tofu, jam, marmalade, cocoa, chocolate, noodles, and mashed potatoes. A specific offering is distilled diglycerine ester, a compound resulting from the interaction of diglycerine with fatty acids. To prolong shelf life, Riken Vitamin supplies natural tocopherol, an antioxidant that prevents oxidation and maintains food freshness. Their product line further encompasses natural food colors and various flavorings suitable for seasoning seafood, poultry, and beef. The company also deals in wakame seaweed, frequently utilized in soups, salads, and instant noodle preparations, alongside integrated stabilizing and emulsifying solutions for frozen treats and dairy products. Additionally, they develop specialized bakery emulsifiers, bread improvers, and cake-enhancing agents. In the chemical realm, Riken Vitamin offers various improving agents, including glycerol, polyglycerol, sorbitan, propylene glycol, and other specialty esters, in addition to vitamins. Established in 1917, the company was initially known as Riken Vitamin Oil Co., Ltd. before rebranding as Riken Vitamin Co., Ltd. in 1980.
